More @sydneyhealthlitlab.bsky.social research from the @publichealthaus.bsky.social #Screening2025 conference, with a focus on psychosocial support to enable informed decision making about breast and lung cancer screening @jenna-smith.bsky.social @brookenickel.bsky.social @kmcfadden.bsky.social
Was great to present this morning at #Screening2025 on our research showing Australians are positive 👍about #genomic-risk based #cancer screening, but want more ⬆️ comprehensive tests and have concerns ❓about equity.
#AustralianCancerRiskStudy@sydneyuni.bsky.social @publichealthaus.bsky.social
A panel of experts on stage.
An exciting start to day two of #Screening2025, discussing new and emerging screening opportunities for chronic diseases like diabetes and dementia.
Day 1 of #Screening2025 closes with reflections from community & patient perspectives, including GP @rosemarywyber.bsky.social highlighting the importance of shared decision making with Aboriginal & Torres Strait Islander communities & holistic discussions over time. @publichealthaus.bsky.social
Fortunate to be here at the #Screening2025 conference! A great theme focusing on maximising benefits and minimising harms.
I’m looking forward to presenting tomorrow in the psychosocial session at 11am!
I’ll be speaking about my work on supporting older women’s breast cancer screening decisions.
Garry Jennings makes the case for a targeted (as opposed to population) risk screening program in clinical settings for CVD prevention - find out more at my 1.30 concurrent session presentation on the first day of the #Screening2025 conference @publichealthaus.bsky.social
#Screening2025 Next we hear about de-implementing screening where risk reduces (e.g. via HPV vaccination), and more on balancing benefits vs different types of harm (e.g. overdiagnosis, carbon emissions) from @wiserhealthcare.bsky.social epidemiologist @katyjlbell.bsky.social
Great opening session for @publichealthaus.bsky.social #Screening2025. Emphasis on criteria to ensure benefits outweigh harms, and interesting examples of biased industry/media reporting of emerging screening tests. Excited to present a Heart Foundation targeted #CVD risk screening trial at 1.30!
Terry Slevin speaking to crowd
Welcome to #Screening2025! We’re excited for a jam-packed two days in Sydney/Gadigal land, exploring opportunities for disease screening programs and looking at the latest evidence.
